TokyoTokyo Mon - Fri 10:00-18:00 +81 (366) 701-751
info@mountequitygroup.com

Category

Markets
On June 14, IFB Industries reveals earnings for Q4.1 analyst is forecasting earnings of INR 5.30 per share compared to losses of INR 4.550 per share in the same quarter of the previous year.Wall Street is expecting the company to report INR 8.27 billion, an increase of over the prior year quarter when the company...
Read More
Hello readers,Happy Saturday, and welcome to Insider Finance. Here's a rundown of the must-know stories from the past week:
Read More
many part-timers work in the sectors that have been hardest hit by the pandemic, such as hospitality. Betsie Van der Meer
Read More
TOKYO, June 11, 2021 /PRNewswire/ -- In the three months ended March 31, 2021, net sales increased while profit declined. Meanwhile, the Company has formulated its new medium-term management plan, "PROTECT × CHANGE" and is proceeding with its corporate mission of "Protecting the environment and changing the future."Summary of ResultsThe business environment surrounding the Company...
Read More
NEW YORK, June 11, 2021 /PRNewswire/ -- The industrial robots market size in the automotive industry is expected to grow by USD 3.97 billion during 2021-2025, according to the new report from Technavio. The report projects the market to accelerate at a CAGR of almost 7%.Technavio's in-depth market research reports include value chain analysis and validation...
Read More
VANCOUVER, BC, June 11, 2021 /CNW/ - TSX VENTURE COMPANIESBULLETIN TYPE:  Cease Trade OrderBULLETIN DATE:  June 11, 2021TSX Venture CompanyA Cease Trade Order has been issued by the Autorite des Marches Financiers on June 10, 2021 against the following company for failing to file the documents indicated within the required time period:SymbolTier Company Failure to FilePeriodEnding(Y/M/D)QIT       2...
Read More
SHENZHEN, China, June 11, 2021 /PRNewswire/ -- ImmVira announced that in the Phase II Clinical Trials of its leading oncolytic virus product, MVR-T3011* as intratumoral administration (MVR-T3011 IT), ImmVira has completed the first dosing in both China and the U.S. on May 28 2021 and June 11 2021, respectively.MVR-T3011, ImmVira's proprietary next-generation, genetically modified oncolytic...
Read More
1 263 264 265 266 267 287